Best Practices in the Management of Infectious Complications for Cancer Patients

November 5, 2016

Learning Objectives

  • Identify risk factors for febrile or prolonged neutropenia and the potential clinical outcomes of these conditions in oncology patients
  • Assess the role and interchangeability of biosimilar and reference biologic granulocyte colony-stimulating factors in the prophylaxis and treatment of febrile neutropenia
  • Understand the impact of worrisome developments with respect to superinfection and drug resistance
  • Describe treatments for infections commonly seen in patients with cancer as well as what advanced practitioners should be aware of when strategizing a treatment approach
Course summary
Available credit: 
  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC
Course opens: 
11/05/2016
Course expires: 
06/08/2017
Event starts: 
11/05/2016 - 3:45pm
Event ends: 
11/05/2016 - 4:30pm
Cost:
$0.00
Rating: 
5
Gaylord National Hotel
National Harbor, MD
United States

Available Credit

  • 0.75 ACPE
  • 0.75 AMA PRA Category 1 Credit(s)™
  • 0.75 Attendance
  • 0.75 ANCC

Price

Cost:
$0.00
Please login or register to take this course.